Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates The following represents disclosure information provided by authors of this ...
A new study shows Signatera ctDNA testing may identify older patients with ER+/HER2- breast cancer who can manage their care ...
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors From September 7, 2020, to February 27, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results